265 related articles for article (PubMed ID: 8566020)
1. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells.
Plumas J; Chaperot L; Jacob MC; Molens JP; Giroux C; Sotto JJ; Bensa JC
Eur J Immunol; 1995 Dec; 25(12):3332-41. PubMed ID: 8566020
[TBL] [Abstract][Full Text] [Related]
2. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
3. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.
Rondelli D; Anasetti C; Fortuna A; Ratta M; Arpinati M; Bandini G; Lemoli RM; Tura S
Bone Marrow Transplant; 1998 Jun; 21(12):1183-91. PubMed ID: 9674849
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
5. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
[TBL] [Abstract][Full Text] [Related]
6. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
7. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
[TBL] [Abstract][Full Text] [Related]
9. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
10. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
11. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
Subauste CS; de Waal Malefyt R; Fuh F
J Immunol; 1998 Feb; 160(4):1831-40. PubMed ID: 9469444
[TBL] [Abstract][Full Text] [Related]
12. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
Guinn BA; DeBenedette MA; Watts TH; Berinstein NL
J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049
[TBL] [Abstract][Full Text] [Related]
13. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
[TBL] [Abstract][Full Text] [Related]
14. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.
Gajewski TF
J Immunol; 1996 Jan; 156(2):465-72. PubMed ID: 8543795
[TBL] [Abstract][Full Text] [Related]
15. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
Morokata T; Kato T; Igarashi O; Nariuchi H
Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
[TBL] [Abstract][Full Text] [Related]
17. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
[TBL] [Abstract][Full Text] [Related]
18. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE
J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.
Martin-Fontecha A; Cavallo F; Bellone M; Heltai S; Iezzi G; Tornaghi P; Nabavi N; Forni G; Dellabona P; Casorati G
Eur J Immunol; 1996 Aug; 26(8):1851-9. PubMed ID: 8765031
[TBL] [Abstract][Full Text] [Related]
20. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
